This article has been revised and clarified. Pasadena-based biopharma company Arrowhead Pharmaceuticals Inc. had a double-dose of good news last month. On Nov. 18, Arrowhead announced that it had ...

Arrowhead Game Studios has already begun work on its next game, but how does a developer follow a galactic success as beloved as Helldivers 2? Former CEO and current CCO Johan Pilestedt says whatever ...

With a fresh FDA endorsement for its drug plozasiran, California-based Arrowhead Pharmaceuticals has successfully broken through to the commercial realm. Complicating the matter, however, is the fact ...

The Kansas City Chiefs have been one of the NFL’s most dominant teams of the last decade, winning three Super Bowl championships and playing in seven straight AFC Championship games. And while the ...

Close-up of Hyptiotes cavatus spider holding triangle web support line with front legs keeping web open, while using back legs to secure anchor line. When back legs release anchor line, spider and web ...

The Chiefs continue to move toward an inevitable decision between renovating Arrowhead Stadium and building a new stadium. On Monday, Chiefs owner Clark Hunt addressed the status of the team’s effort ...

Pasadena-based Arrowhead Pharmaceuticals Inc. has announced another major licensing deal with a pharma giant. This one is with Basel, Switzerland-based Novartis for $200 million in upfront payment and ...

Sept 11 (Reuters) - Ionis Pharmaceuticals (IONS.O), opens new tab sued biotech rival Arrowhead Pharmaceuticals (ARWR.O), opens new tab for patent infringement in California federal court on Thursday ...

Arrowhead Pharmaceuticals has launched legal action against Ionis Pharmaceuticals, aiming to neutralize Ionis' claim that Arrowhead's potential rival to Tryngolza breaches a patent. Arrowhead claims ...

The announcement of a landmark deal with a pharmaceutical giant validates Arrowhead's technology. For reference, the TRiM platform is a key part of the investment case for the stock. Arrowhead's ...

Novartis has been on a deal-making spree in 2025, including buyouts and licensing pacts, as it prepares for looming patent expirations on several blockbuster medicines. H.C. Wainwright analysts said ...

Nebraska and Cincinnati will play their 2025 season opener at Arrowhead Stadium, a neutral site. The game was originally scheduled to be played in Cincinnati but was moved to Lucas Oil Stadium before ...